Aerovate Therapeutics Inc (NAS:AVTE) Stock News, Headlines & Updates
Aerovate Therapeutics Inc Stock News from GuruFocus
- 1
Jun 21, 2024
Investigation Into Aerovate Therapeutics, Inc. (AVTE) Announced byHolzer & Holzer, LLC
Marketwired • 2:00pm
Jun 20, 2024
Aerovate Therapeutics Investors: Investigation on behalf of investors; the Portnoy Law Firm
Marketwired • 1:00pm
Jun 17, 2024
SHAREHOLDER ALERT: Aerovate Therapeutics Investigated for Securities Fraud Violations by Block & Leviton
Marketwired • 12:00pm
Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
Marketwired • 8:00am
May 21, 2024
Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference
Marketwired • 4:00pm
May 13, 2024
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
Marketwired • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news